MedPath

Effectiveness of the Suicidal Crisis Intervention (SCI)

Not Applicable
Recruiting
Conditions
Suicide, Attempted
Suicide
Suicidal Ideation
Interventions
Behavioral: Suicidal Crisis Intervention (SCI)
Registration Number
NCT05638204
Lead Sponsor
University Hospital, Ghent
Brief Summary

The main objective of this project is to be able to offer a new, specific evidence-based short-term treatment method, the Suicidal Crisis Intervention (SCI), to reduce suicidality. In addition, this study aims to investigate the influence of SCI on other important aspects of suicidality (secondary goal) such as hopelessness, defeat, entrapment, and interpersonal needs.

Detailed Description

Research has extensively shown that a previous suicide attempt or a history of suicide attempts are important predictors of suicide death. It is therefore important to provide people with appropriate care after a suicide attempt to limit this risk.

Although this risk factor (previous attempts) is known, the number of interventions developed for this risk group is limited.

Based on these findings, a short-term treatment trajectory was developed for people after a suicide attempt or a suicidal crisis in Flanders, called the Suicidal Crisis Intervention (SCI). This was inspired by the ASSIP treatment trajectory and the safety plan was also given a significant place within the treatment. In addition, the importance of relatives and social support is emphasized by involving relatives in this treatment. Throughout this treatment, further (treatment) goals are drawn up, in order to generate hope for improvement and to facilitate continuity of care. More information about the concrete content of SCI will follow later in this protocol. A pilot study is currently being conducted to assess the feasibility of this treatment, as well as the experience of patients, relatives and care providers. Based on this, the SCI will be further updated for this effectiveness study.

There are currently no specific evidence-based short-term treatment methods in Flanders for people after a suicidal crisis or suicide attempt. The primary research question is therefore: 'Is the Suicidal Crisis Intervention (SCI) in Flanders an effective short-term treatment method for people after a suicidal crisis or suicide attempt?'.

The main objective of this project is to be able to offer a new, specific short-term treatment method that has been scientifically proven to reduce suicidality. In addition, we want to investigate the influence of SCI on other important aspects of suicidality (secondary goal) such as hopelessness, defeat, entrapment, and interpersonal needs.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
390
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupSuicidal Crisis Intervention (SCI)Participants in the intervention group received the Suicidal Crisis Intervention( SCI) in addition to their treatment as usual.
Primary Outcome Measures
NameTimeMethod
Change in suicidality: Beck Scale for Suicide Ideation (BSI; Beck & Steer, 1991)Change in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

The BSI is a 21-item self-report questionnaire. Each item is rated on a scale from 0 to 2, resulting in a total score ranging from 0 to 38.

Secondary Outcome Measures
NameTimeMethod
Change in isolation: Interpersonal Needs Questionnaire (INQ; Van Orden et al., 2012; Hill et al., 2015) - short versionChange in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

This is a 10-item questionnaire where each item is rated on a 7-point Likert scale with 1= Not at all true for me, 4 = somewhat true for me and 7 = very true for me.

Change in defeat: Defeat Scale (DS; Gilbert & Allen, 1998; Griffiths et al., 2015) - short versionChange in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

A 4-item self-report questionnaire to measure defeat on a five-point Likert scale. A total score ranging from 0 to 16 is obtained, with higher scores indicating more perceptions of defeat (worse outcome).

Treatment satisfaction [own questionnaire]Post-test [42 days after randomization]

To investigate how patients of the intervention group experienced the SCI, some evaluative questions are asked. Participants are asked to indicate how many sessions they received, how they would rate the treatment \[0-10\], what they thought of the number and length of sessions \[too little/short, good, too many/long\], rate to what degree they agreed \[strongly disagree, disagree, neutral, agree, strongly agree, not applicable\] with 8 statements about the treatment, and 2 open questions about the strengths, weaknesses of the treatment.

Change in suicidal behaviourChange in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

Using two questions participants will be asked whether they have experienced suicidal thoughts (lifetime and since last measure, or last year for baseline) and whether they attempted suicide (lifetime and since last measure, or last year for baseline)

Change in hopelessness: The Beck Hopelessness Scale (BHS; Beck et al., 1974)Change in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

A 20-item self-report questionnaire to measure hopelessness in adolescents and adults. Each item is rated as 'true' (score = 1) or 'false' (score = 0) for them over the past week, resulting in a total score ranging from 0 to 20, with higher scores indicating higher levels of hopelessness (worse outcome).

Change in entrapment: Entrapment Scale (ES; Gilbert & Allen, 1998; Griffiths et al., 2015) - short versionChange in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

A 4-item self-report questionnaire to measure entrapment on a five-point Likert scale. A total score ranging from 0 to 16 is obtained, with higher scores indicating more perceptions of entrapment (worse outcome).

Change in (prepared to follow) follow-up care [own questionnaire]Change in baseline to post-test [42 days after randomization], to follow-up 1 [132 days after randomization] and to follow-up 2 [222days after randomization]

To assess whether participants receive follow-up care or are prepared to receive follow-up care, 14 questions were asked. About which psychological \[none, GP, psychologist, psychiatrist, other health care worker, residential care, waiting list\], medical \[no medication, pain killers, tranquilizers/anxiolytics, sleeping pills, antidepressants, antipsychotics, other\] treatment they were currently receiving, they started/stopped/changed since the start of the study and or prepared to receive. This will not result in a total score, but instead will be used as a descriptive questionnaire.

Trial Locations

Locations (12)

Psychiatrisch Centrum Sint Amandus (incl. Mobiel Crisis Team)

🇧🇪

Beernem, Belgium

UZ Gent

🇧🇪

Gent, Belgium

Openbaar Psychiatrisch Zorgcentrum Geel

🇧🇪

Geel, Belgium

Mobiel Crisis Team zorggroep Multiversum

🇧🇪

Boechout, Belgium

Psychiatrisch Ziekenhuis Heilige Familie Kortrijk

🇧🇪

Kortrijk, Belgium

Psychiatrisch Centrum Ariadne

🇧🇪

Lede, Belgium

Psychiatrisch Ziekenhuis Sint Lucia (incl. Mobiel Team Acute Zorgen)

🇧🇪

Sint-Niklaas, Belgium

Medisch Centrum St. Jozef

🇧🇪

Bilzen, Belgium

AZ Groeninge (incl. Mobiel Crisis Team Kortrijk)

🇧🇪

Kortrijk, Belgium

Openbaar Psychiatrisch Zorgcentrum Rekem

🇧🇪

Rekem, Belgium

Algemeen Ziekenhuis Glorieux

🇧🇪

Ronse, Belgium

Bethanië GGZ (incl. mobiel crisis team SARA Het Veer)

🇧🇪

Zoersel, Belgium

© Copyright 2025. All Rights Reserved by MedPath